Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic acid for neonatal jaundice in G6PD-deficient neonates
IRCT20190604043813N2Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ursodeoxycholic acid in neonatal hyperbilirubinemia (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Total bilirubin, Median admission time and 1 more. Started Apr 2020; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT20190604043813N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190604043813N2.